Promoter hypermethylation has been described as a main pathway for inactivation of CDKN2A for SCC of the esophagus [6, 24], while deletion appears to happen early in the development of Barrett’s mucosa [13], a recognized precursor lesion for esophageal AC. This evidence concerns the gene CDKN2A and esophageal squamous cell carcinoma.